Published in J Infect Dis on August 01, 1993
The continuing challenges of leprosy. Clin Microbiol Rev (2006) 4.09
Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset. J Exp Med (1998) 2.39
Thalidomide treatment reduces tumor necrosis factor alpha production and enhances weight gain in patients with pulmonary tuberculosis. Mol Med (1995) 1.46
Immunomodulation by thalidomide and thalidomide analogues. Ann Rheum Dis (1999) 1.40
The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen- and antigen-stimulated human peripheral blood mononuclear cell cultures. Clin Exp Immunol (1995) 1.37
Potential plasma markers of Type 1 and Type 2 leprosy reactions: a preliminary report. BMC Infect Dis (2009) 1.26
Selection of novel analogs of thalidomide with enhanced tumor necrosis factor alpha inhibitory activity. Mol Med (1996) 1.24
Thalidomide and derivatives: immunological investigations of tumour necrosis factor-alpha (TNF-alpha) inhibition suggest drugs capable of selective gene regulation. Clin Exp Immunol (1997) 1.10
Cellular immune response to Mycobacterium leprae infection in human immunodeficiency virus-infected individuals. Infect Immun (1995) 1.10
Integrated pathways for neutrophil recruitment and inflammation in leprosy. J Infect Dis (2010) 1.00
Mycobacterium leprae-host-cell interactions and genetic determinants in leprosy: an overview. Future Microbiol (2011) 1.00
Pentoxifylline decreases in vivo and in vitro tumour necrosis factor-alpha (TNF-alpha) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL). Clin Exp Immunol (1998) 0.96
Binding of thalidomide to alpha1-acid glycoprotein may be involved in its inhibition of tumor necrosis factor alpha production. Proc Natl Acad Sci U S A (1996) 0.96
Thalidomide analogues as anticancer drugs. Recent Pat Anticancer Drug Discov (2007) 0.92
A single oral dose of thalidomide enhances the capacity of lymphocytes to secrete gamma interferon in healthy humans. Antimicrob Agents Chemother (2000) 0.92
Disseminated herpes simplex virus and varicella zoster virus coinfection in a patient taking thalidomide for relapsed multiple myeloma. J Clin Microbiol (2002) 0.92
The treatment of advanced renal cell cancer with high-dose oral thalidomide. Br J Cancer (2001) 0.88
Optimal management of cancer anorexia-cachexia syndrome. Cancer Manag Res (2010) 0.86
Treatment of pediatric refractory Crohn's disease with thalidomide. World J Gastroenterol (2011) 0.81
Thalidomide analogue CC1069 inhibits development of rat adjuvant arthritis. Clin Exp Immunol (1999) 0.81
The thalidomide analogue CC-3052 inhibits HIV-1 and tumour necrosis factor-alpha (TNF-alpha) expression in acutely and chronically infected cells in vitro. Clin Exp Immunol (2000) 0.81
IgG1 antimycobacterial antibodies can reverse the inhibitory effect of pentoxifylline on tumour necrosis factor alpha (TNF-alpha) secreted by mycobacterial antigen-stimulated adherent cells. Clin Exp Immunol (2004) 0.80
Effects of thalidomide on intracellular Mycobacterium leprae in normal and activated macrophages. Clin Diagn Lab Immunol (2005) 0.77
The influence of innate and adaptative immune responses on the differential clinical outcomes of leprosy. Infect Dis Poverty (2017) 0.76
Inhibitory effects of thalidomide on cellular proliferation, endoneurial edema and myelin phagocytosis during early wallerian degeneration. Acta Neuropathol (1995) 0.76
Effect of thalidomide and arsenic trioxide on the release of tumor necrosis factor-α and vascular endothelial growth factor from the KG-1a human acute myelogenous leukemia cell line. Oncol Lett (2010) 0.75
A Systematic Review of Immunological Studies of Erythema Nodosum Leprosum. Front Immunol (2017) 0.75
Thalidomide is Associated With Increased T Cell Activation and Inflammation in Antiretroviral-naive HIV-infected Individuals in a Randomised Clinical Trial of Efficacy and Safety. EBioMedicine (2017) 0.75
[Cytokine regulation and pain. Results of experimental and clinical research]. Schmerz (2008) 0.75
Identification of a novel cell type in peripheral lymphoid organs of mice. V. Purification of spleen dendritic cells, new surface markers, and maintenance in vitro. J Exp Med (1979) 8.32
Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha /beta. Proc Natl Acad Sci U S A (2001) 5.21
Cap-independent translation of poliovirus mRNA is conferred by sequence elements within the 5' noncoding region. Mol Cell Biol (1988) 4.97
Human dendritic cells. Enrichment and characterization from peripheral blood. J Exp Med (1982) 4.49
Income inequality, the psychosocial environment, and health: comparisons of wealthy nations. Lancet (2001) 4.48
Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes. J Exp Med (1991) 4.43
Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates. J Immunol (1999) 4.15
Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy. N Engl J Med (1986) 4.05
Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha. J Immunol (1999) 3.99
Relation between income inequality and mortality: empirical demonstration. BMJ (1999) 3.98
Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guérin. J Exp Med (1994) 3.94
The cutaneous infiltrates of leprosy: cellular characteristics and the predominant T-cell phenotypes. N Engl J Med (1982) 3.52
[Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey. 85 cases]. Rev Rhum Mal Osteoartic (1987) 3.40
Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. J Exp Med (1993) 3.31
The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry (2006) 2.80
Defective gamma interferon production in leprosy. Reversal with antigen and interleukin 2. J Exp Med (1983) 2.61
Pyoderma gangrenosum: an updated review. J Eur Acad Dermatol Venereol (2009) 2.60
Mutational analysis of upstream AUG codons of poliovirus RNA. J Virol (1988) 2.55
Staphylococcus aureus RN6390 replicates and induces apoptosis in a pulmonary epithelial cell line. Infect Immun (2000) 2.54
Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset. J Exp Med (1998) 2.39
Mycobacterium leprae antigen-induced suppression of T cell proliferation in vitro. J Immunol (1987) 2.27
Polymerase chain reaction for diagnosis of enterohemorrhagic Escherichia coli infection and hemolytic-uremic syndrome. J Clin Microbiol (1992) 2.24
Arachidonic acid metabolism by human monocytes. Studies with platelet-depleted cultures. J Exp Med (1983) 2.24
Perforin, a cytotoxic molecule which mediates cell necrosis, is not required for the early control of mycobacterial infection in mice. Infect Immun (1997) 2.19
Cellular responses to the intradermal injection of recombinant human gamma-interferon in lepromatous leprosy patients. Am J Pathol (1987) 2.18
Influence of delayed immune reactions on human epidermal keratinocytes. Proc Natl Acad Sci U S A (1986) 2.11
Antigen-specific T lymphocytes efficiently cluster with dendritic cells in the human primary mixed-leukocyte reaction. Cell Immunol (1988) 2.08
In vitro differentiation of human monocytes. Differences in monocyte phenotypes induced by cultivation on glass or on collagen. J Exp Med (1982) 2.02
Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments. Aliment Pharmacol Ther (2015) 1.99
Characterization of poliovirus conformational alteration mediated by soluble cell receptors. Virology (1993) 1.97
Serum levels of tumour necrosis factor-alpha and interleukin-1 beta during leprosy reactional states. Clin Exp Immunol (1991) 1.94
Acupuncture for osteoarthritis of the knee: a systematic review. Arthritis Rheum (2001) 1.91
Relationship between premature mortality and socioeconomic factors in black and white populations of US metropolitan areas. Public Health Rep (2002) 1.91
Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent. Infect Immun (2000) 1.91
Mycobacterium tuberculosis catalase and peroxidase activities and resistance to oxidative killing in human monocytes in vitro. Infect Immun (1999) 1.90
Translational efficiency of poliovirus mRNA: mapping inhibitory cis-acting elements within the 5' noncoding region. J Virol (1988) 1.85
Analysis of naturally occurring delayed-type hypersensitivity reactions in leprosy by in situ hybridization. J Exp Med (1989) 1.82
Fc-receptor variants of a mouse macrophage cell line. Proc Natl Acad Sci U S A (1979) 1.80
TNF-alpha controls intracellular mycobacterial growth by both inducible nitric oxide synthase-dependent and inducible nitric oxide synthase-independent pathways. J Immunol (2001) 1.79
In vitro synthesis of infectious poliovirus RNA. Proc Natl Acad Sci U S A (1985) 1.78
Distribution and turnover of Langerhans cells during delayed immune responses in human skin. J Exp Med (1987) 1.74
Differences in the mode of phagocytosis with Fc and C3 receptors in macrophages. Scand J Immunol (1977) 1.71
The distinctive features of influenza virus infection of dendritic cells. Immunobiology (1998) 1.70
Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patients. J Exp Med (1992) 1.63
Amino-substituted thalidomide analogs: potent inhibitors of TNF-alpha production. Bioorg Med Chem Lett (1999) 1.62
Juvenile chronic arthritis: diagnosis and management of tibio-talar and sub-talar disease. Br J Rheumatol (1997) 1.62
Selective increase in plasma tumor necrosis factor-alpha and concomitant clinical deterioration after initiating therapy in patients with severe tuberculosis. J Infect Dis (1998) 1.62
Thalidomide inhibits the replication of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1993) 1.61
Insertion and turnover of macrophage plasma membrane proteins. Proc Natl Acad Sci U S A (1979) 1.60
Ultrafast computed tomography-detected coronary calcium reflects the angiographic extent of coronary arterial atherosclerosis. Am J Cardiol (1994) 1.59
Role of activated macrophages in antibody-dependent lysis of tumor cells. J Exp Med (1980) 1.58
Comparable growth of virulent and avirulent Mycobacterium tuberculosis in human macrophages in vitro. J Infect Dis (1996) 1.55
An analysis of in vitro T cell responsiveness in lepromatous leprosy. J Exp Med (1985) 1.52
The cutaneous infiltrates of leprosy. A transmission electron microscopy study. J Exp Med (1983) 1.51
Component-resolved diagnosis of vespid venom-allergic individuals: phospholipases and antigen 5s are necessary to identify Vespula or Polistes sensitization. Allergy (2012) 1.48
Use of acupuncture by American physicians. J Altern Complement Med (1997) 1.47
Group B streptococcal vertebral osteomyelitis with bacteraemia in an adult with no debilitating condition. Scand J Infect Dis (1999) 1.47
Identification of immunostimulatory dendritic cells in the synovial effusions of patients with rheumatoid arthritis. J Clin Invest (1985) 1.47
Thalidomide treatment reduces tumor necrosis factor alpha production and enhances weight gain in patients with pulmonary tuberculosis. Mol Med (1995) 1.46
Allergy to penicillin with good tolerance to other penicillins; study of the incidence in subjects allergic to beta-lactams. Clin Exp Allergy (1990) 1.45
Adjunctive thalidomide therapy of childhood tuberculous meningitis: possible anti-inflammatory role. J Child Neurol (2000) 1.44
Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits Mycobacterium smegmatis-induced cytokine production by human macrophages in vitro. Infect Immun (2001) 1.44
Changes in total RNA, polyadenylated RNA, and actin mRNA during meiotic maturation of mouse oocytes. Dev Biol (1985) 1.43
Survival of Mycobacterium avium and Mycobacterium tuberculosis in acidified vacuoles of murine macrophages. Infect Immun (1999) 1.43
Immunomodulation by thalidomide and thalidomide analogues. Ann Rheum Dis (1999) 1.40
[Progression to IDDM and islet cell antibodies (ICA; ICA-CF)]. J Pediatr (Rio J) (2003) 1.39
H2O2 induces monocyte apoptosis and reduces viability of Mycobacterium avium-M. intracellulare within cultured human monocytes. Infect Immun (1996) 1.39
How Mycobacterium leprae infects peripheral nerves. Lepr Rev (1999) 1.39
Anaphylaxis caused by imported red fire ant stings in Málaga, Spain. J Investig Allergol Clin Immunol (2007) 1.39
Recognition and destruction of Bacillus Calmette-Guerin-infected human monocytes. J Exp Med (1993) 1.39
Tumor necrosis factor alpha is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system. Proc Natl Acad Sci U S A (1999) 1.38
A combination of thalidomide plus antibiotics protects rabbits from mycobacterial meningitis-associated death. J Infect Dis (1998) 1.37
The immunobiology of leprosy. Int Rev Exp Pathol (1986) 1.35
Cutaneous leishmaniasis. The defect in T cell influx in BALB/c mice. J Exp Med (1987) 1.34
Heterogeneous expression of poliovirus receptor-related proteins in human cells and tissues. Mol Cell Biol (1990) 1.34
Mechanism of in vitro synthesis of covalently linked dimeric RNA molecules by the poliovirus replicase. J Virol (1986) 1.30
Differences in prevalence and extent of coronary artery calcium detected by ultrafast computed tomography in asymptomatic men and women. Am J Cardiol (1993) 1.27
Identification of Streptococcus suis isolated from swine: proposal for biochemical parameters. J Clin Microbiol (1994) 1.25
Selection of novel analogs of thalidomide with enhanced tumor necrosis factor alpha inhibitory activity. Mol Med (1996) 1.24
Susceptibility of nonprimate cell lines to hepatitis A virus infection. J Virol (1994) 1.23
The selective binding and transmigration of monocytes through the junctional complexes of human endothelium. J Exp Med (1988) 1.23
The generation of antigen-specific, major histocompatibility complex-restricted cytotoxic T lymphocytes of the CD4+ phenotype. Enhancement by the cutaneous administration of interleukin 2. J Exp Med (1989) 1.22
Macrophage activation in vivo and in vitro. Exp Cell Res (1977) 1.22
VP1 of serotype C foot-and-mouth disease viruses: long-term conservation of sequences. J Virol (1988) 1.22
Keratinocyte growth regulation by the products of immune cells. J Exp Med (1988) 1.19
Suppression of T-cell proliferation by Mycobacterium leprae and its products: the role of lipopolysaccharide. Proc Natl Acad Sci U S A (1990) 1.18
High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis. Am J Cardiol (1998) 1.18
Effect of cytokine modulation by thalidomide on the granulomatous response in murine tuberculosis. Tuber Lung Dis (1997) 1.18
A high-density SNP linkage scan with 142 combined subtype ADHD sib pairs identifies linkage regions on chromosomes 9 and 16. Mol Psychiatry (2008) 1.18
A technique of nonsuture wound closure with a plastic tissue adhesive. Plast Reconstr Surg (1966) 1.18
Use of ML dipstick as a tool to classify leprosy patients. Int J Lepr Other Mycobact Dis (2000) 1.16
On the mechanism of internalization of opsonized particles by rat Kupffer cells in vitro. Exp Cell Res (1976) 1.15